Glycoconjugate vaccines based on bacterial capsular polysaccharides (CPS) have been
extremely successful in preventing bacterial infections. The glycan antigens for the …

Vaccination is the most cost-efficient and the most powerful medical intervention in the
control, prevention and eradication of many diseases that affect human population. Capsular …

Glycoconjugate vaccines obtained by chemical linkage of a carbohydrate antigen to a
protein are part of routine vaccinations in many countries. Licensed antimicrobial glycan …

Glycoconjugate vaccines against bacteria are one of the success stories of modern
medicine and have led to a significant reduction in the global occurrence of bacterial …

The surface of cells is coated with a dense layer of glycans, known as the cell glycocalyx.
The complex glycans in the glycocalyx are involved in various biological events, such as …

Carbohydrate-based vaccines constitute successful therapeutic arsenals against microbial
infections, particularly since the advent of bacterial capsular polysaccharide (CPS) protein …

Vaccinations provide an efficient and cost-effective way to combat devastating human
diseases. Besides pathogenic protein markers, cell surface carbohydrates from biological …

The glycocalyx, a thick layer of carbohydrates, surrounds the cell wall of most bacterial and
parasitic pathogens. Recognition of these unique glycans by the human immune system …

Cell surface carbohydrates have been proven optimal targets for vaccine development.
Conjugation of polysaccharides to a carrier protein triggers a T-cell-dependent immune …

During the last decade there has been a growing interest in glycoimmunology, a relatively
new research field dealing with the specific interactions of carbohydrates with the immune …